You are here » Home » Companies » Company Overview » Divis Laboratories Ltd

Divis Laboratories Ltd.

BSE: 532488 Sector: Health care
NSE: DIVISLAB ISIN Code: INE361B01024
BSE LIVE 15:52 | 02 Dec 1135.30 -13.70
(-1.19%)
OPEN

1145.00

HIGH

1145.00

LOW

1122.00

NSE LIVE 15:43 | 02 Dec 1135.85 -14.50
(-1.26%)
OPEN

1140.00

HIGH

1145.20

LOW

1122.40

OPEN 1145.00
PREVIOUS CLOSE 1149.00
VOLUME 8104
52-Week high 1380.00
52-Week low 918.10
P/E 27.54
Mkt Cap.(Rs cr) 30136.54
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1145.00
CLOSE 1149.00
VOLUME 8104
52-Week high 1380.00
52-Week low 918.10
P/E 27.54
Mkt Cap.(Rs cr) 30136.54
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Divis Laboratories Ltd.

Divis Laboratories Ltd

Divi's Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of generic APIs custom synthesis of active ingredients and other specialty chemicals such as peptides and nutraceuticals. The company has three multi-purpose manufacturing facilities with a total reactor capacity of 4500 cubic meter and all sup...> More

Divis Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   30,137
EPS - TTM () [*S] 41.23
P/E Ratio (X) [*S] 27.54
Face Value ()   2
Latest Dividend (%)   500.00
Latest Dividend Date 17 Mar 2016
Dividend Yield (%) 0.88
Book Value / Share () [*S] 183.88
P/B Ratio () [*S] 6.17
[*C] Consolidated     [*S] Standalone

Divis Laboratories Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 1005.43 971.69 3.47
Other Income 20.27 30 -32.43
Total Income 1025.7 1001.69 2.4
Total Expenses 714.22 595.54 19.93
Operating Profit 311.48 406.15 -23.31
Net Profit 223.85 296.9 -24.6
Equity Capital 53.09 53.09 -
> More on Divis Laboratories Ltd Financials Results

Divis Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Cipla 571.40 0.57 45954.85
Aurobindo Pharma 719.40 -3.24 42099.29
Cadila Health. 395.25 -1.09 40461.74
Divi's Lab. 1135.30 -1.19 30136.54
Piramal Enterp. 1638.05 0.14 28264.55
Glenmark Pharma. 863.05 -1.51 24355.27
Glaxosmit Pharma 2715.30 1.01 22998.59
> More on Divis Laboratories Ltd Peer Group

Divis Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 52.06
Banks/FIs 0.28
FIIs 20.91
Insurance 0.00
Mutual Funds 13.25
Indian Public 7.17
Custodians 0.00
Other 6.32
> More on Divis Laboratories Ltd Share Holding Pattern

Divis Laboratories Ltd - Research Reports

Date Broker Action Price Report
02/11 Motilal Oswal Neutral 1150 PDF IconDetails
> More on Divis Laboratories Ltd Research Reports

Divis Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -1.89% -1.66% -0.33% -0.34%
1 Month -10.56% -9.83% -4.71% -4.69%
3 Month -13.66% -13.61% -8.07% -8.21%
6 Month -0.66% -0.43% -2.28% -1.63%
1 Year -0.29% 0.82% 0.43% 2.83%
3 Year 95.75% 97.21% 25.52% 30.39%

Divis Laboratories Ltd - STOCK STRENGTH

Today's Low/High 1122.00
1145.00
Week Low/High 1122.00
1192.00
Month Low/High 1111.00
1319.00
YEAR Low/High 918.10
1380.00
All TIME Low/High 7.70
1380.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard